Fig. 2From: Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohortsAssociation of thrombocytosis (platelet count ≥350 × 109/L) with COPD morbidity (dichotomous outcomes). aOR: adjusted odds ratio; mMRC: modified medical research council questionnaire; CAT: COPD assessment test; GOLD: Global Initiative for Chronic Obstructive Lung Disease. Statistical significance (p < 0.05) denoted by asteriskBack to article page